Built site for gh-pages

.nojekyll

@@ -1 +1 @@
-6035dd7c
+0c41c298

authors.html

@@ -249,6 +249,18 @@ <h1 class="title"><span class="chapter-number">11</span>&nbsp; <span class="chap
 <td>The Netherlands</td>
 </tr>
 <tr class="odd">
+<td><a href="https://orcid.org/0000-0002-6188-0254">Carl de Moor</a></td>
+<td>Certara</td>
+<td>Cambridge, MA</td>
+<td>United States</td>
+</tr>
+<tr class="even">
+<td><a href="https://orcid.org/0000-0002-4444-0943">Changyu Shen</a></td>
+<td>Biogen</td>
+<td>Cambridge, MA</td>
+<td>United States</td>
+</tr>
+<tr class="odd">
 <td><a href="https://orcid.org/0009-0008-1637-6199">Christina Read</a></td>
 <td>Utrecht University</td>
 <td>Utrecht</td>
@@ -261,6 +273,18 @@ <h1 class="title"><span class="chapter-number">11</span>&nbsp; <span class="chap
 <td>United States</td>
 </tr>
 <tr class="odd">
+<td><a href="https://orcid.org/0000-0001-5705-8615">Fabio Pellegrini</a></td>
+<td>Biogen Spain</td>
+<td>Madrid</td>
+<td>Spain</td>
+</tr>
+<tr class="even">
+<td><a href="https://orcid.org/0000-0001-9310-6274">Gabrielle Simoneau</a></td>
+<td>Biogen Canada</td>
+<td>Toronto</td>
+<td>Canada</td>
+</tr>
+<tr class="odd">
 <td><a href="https://orcid.org/0000-0001-5536-8038">Grammati Sarri</a></td>
 <td>Cytel Inc.</td>
 <td>London</td>
@@ -284,6 +308,12 @@ <h1 class="title"><span class="chapter-number">11</span>&nbsp; <span class="chap
 <td>Bern</td>
 <td>Switzerland</td>
 </tr>
+<tr class="odd">
+<td><a href="https://orcid.org/0000-0002-6887-5706">Tammy Jiang</a></td>
+<td>Biogen</td>
+<td>Cambridge, MA</td>
+<td>United States</td>
+</tr>
 </tbody>
 </table>
 

chapter_10.html

@@ -860,16 +860,16 @@ <h3 data-number="6.3.1" class="anchored" data-anchor-id="interventions-for-coron
    plus standard error of the mean:
 
               Mean      SD  Naive SE Time-series SE
-d.STD.REM  -0.1079 0.09934 0.0005735      0.0008589
-d.STD.TOCI -0.1120 0.08303 0.0004794      0.0008486
-sd.d        0.1143 0.08883 0.0005129      0.0017646
+d.STD.REM  -0.1081 0.09896 0.0005714      0.0009396
+d.STD.TOCI -0.1135 0.08362 0.0004828      0.0008865
+sd.d        0.1127 0.08833 0.0005099      0.0017598
 
 2. Quantiles for each variable:
 
-                2.5%      25%      50%      75%   97.5%
-d.STD.REM  -0.317732 -0.16269 -0.10377 -0.05037 0.08634
-d.STD.TOCI -0.259683 -0.16346 -0.11920 -0.06966 0.08132
-sd.d        0.005441  0.04668  0.09515  0.16077 0.33136</code></pre>
+               2.5%      25%      50%      75%   97.5%
+d.STD.REM  -0.32099 -0.16273 -0.10451 -0.04981 0.08643
+d.STD.TOCI -0.26144 -0.16488 -0.12133 -0.07040 0.08023
+sd.d        0.00336  0.04572  0.09351  0.15926 0.33097</code></pre>
 </div>
 </div>
 <p>The corresponding odds ratios are as follows:</p>
@@ -1342,12 +1342,12 @@ <h3 data-number="6.3.3" class="anchored" data-anchor-id="advanced-therapies-for-
 <span id="cb24-5"><a href="#cb24-5" aria-hidden="true" tabindex="-1"></a>sucra.uc<span class="sc">$</span>ranking.random</span></code><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></pre></div>
 <div class="cell-output cell-output-stdout">
 <pre><code> ADA160/80     FIL100     FIL200 GOL200/100      INF10       INF5    OZA0.92 
-0.27727273 0.18818182 0.39818182 0.62636364 0.60636364 0.73272727 0.80000000 
+0.28000000 0.16272727 0.45090909 0.64818182 0.59454545 0.75272727 0.76545455 
        PBO      TOF10      UPA45       UST6     VED300 
-0.01909091 0.39909091 0.97636364 0.35636364 0.62000000 </code></pre>
+0.01636364 0.39545455 0.96818182 0.34181818 0.62363636 </code></pre>
 </div>
 </div>
-<p>These results indicate that 97.6% of the evaluated treatments are worse than <code>UPA45</code>.</p>
+<p>These results indicate that 96.8% of the evaluated treatments are worse than <code>UPA45</code>.</p>
 </section>
 </section>
 <section id="version-info" class="level2 unnumbered">